Actavis to buy Warner Chilcott in $5 billion stock deal
By Caroline Humer and Ransdell Pierson (Reuters) - Generic drugmaker Actavis Inc, itself a recent takeover target, said on Monday it...
Read More »By Caroline Humer and Ransdell Pierson (Reuters) - Generic drugmaker Actavis Inc, itself a recent takeover target, said on Monday it...
Read More »
By Padraic Halpin and Jessica Toonkel DUBLIN/NEW YORK (Reuters) - Royalty Pharma raised its hostile bid for Elan to $12.50 per share...
Read More »
By Dorene Internicola NEW YORK (Reuters) - Fitness experts are shining a new light on group classes from Zumba to yoga because they ...
Read More »By Genevra Pittman NEW YORK (Reuters Health) - Boys who are diagnosed with attention-deficit/hyperactivity disorder (ADHD) in elemen...
Read More »By Genevra Pittman NEW YORK (Reuters Health) - A newer version of the whooping cough vaccine doesn't protect kids as well as the ori...
Read More »
By Randy Fabi and Nilufar Rizki JAKARTA (Reuters) - When a sick Indonesian baby died after 10 hospitals in Jakarta turned her family...
Read More »LONDON (Reuters) - Saudi Arabia has reported another case of infection in a concentrated outbreak of a new strain of a virus that em...
Read More »COPENHAGEN (Reuters) - Danish pharmaceutical group Lundbeck and Japanese partner Takeda said on Saturday that data from clinical pha...
Read More »By Trevor Stokes NEW YORK (Reuters Health) - A review of past research finds that fever-reducing drugs have no effect on the speed o...
Read More »By Trevor Stokes NEW YORK (Reuters Health) - A review of past research finds that fever-reducing drugs have no effect on the speed o...
Read More »